To reduce the burden of chronic lung diseases, the Lung Alliance Netherlands has designed a National Action programme on Chronic Lung Diseases. It aims to improve healthcare coordination, thereby reducing the burden of chronic lung diseases, by focussing on five objectives to be achieved within five years: (1) a 25% reduction in hospitalisation days for asthma and chronic obstructive pulmonary disease; (2) a 15% reduction in working days lost due to respiratory diseases; (3) a 20% improved cost-effectiveness of inhalation medication; (4) a 25% reduction of adolescents taking up smoking; and (5) a 10% reduction of mortality due to asthma and chronic obstructive pulmonary disease.
Methods/design
Baseline data were collected from Dutch registries with the most recent available data from 2011, 2012 and 2013. To achieve the objectives, the Lung Alliance Netherlands presented various key activities and strategies that are described in this paper.
Discussion
The ambitious objectives are interconnected and their mutual reinforcement is expected to have a beneficial impact on the burden of chronic lung diseases. A strength of the Dutch national action programme is the extensive cooperation between the multiple healthcare parties that contribute to the coordination of the delivery of healthcare. A potential weakness is the relatively short time span of the programme, which may prevent observing its full potential.
BurneyPJarvisDPerez-PadillaR. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis2015; 19: 10–20.
2.
KleinJCaspersIDooperM. Longziekten, feiten en cijfers 2013. [Lung diseases, facts and figures 2013], Amersfoort: Long Alliantie Nederland, 2013.
3.
SchäferWKronemanMBoermaW. The Netherlands: health system review. Health Syst Transit2010; 12: 1–228.
4.
Poos MJJC. Sterfte naar doodsoorzaak: Waaraan overlijden mensen in Nederland? [Mortality by cause of death: What is the cause of death in people in the Netherlands?]. Bilthoven: Nationaal Kompas Volksgezondheid – RIVM, 2013.
5.
LozanoRNaghaviMForemanK. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012; 380: 2095–2128.
6.
YorganciogluACruzAABousquetJ. The Global Alliance against Respiratory Diseases (GARD) country report. Prim Care Respir J2014; 23: 98–101.
7.
Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. New York: United Nations, General Assembly, 2011.
8.
Betere en doelmatigere longzorg [Better and efficient pulmonary care]. Amersfoort: Long Alliantie Nederland, 2014.
9.
KinnulaVLVasankariTKontulaE. The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J2011; 20: 178–183.
Suijkerbuijk AWM, Poos MJJC and Slobbe LCJ. Astma: Hoeveel zorg gebruiken patiënten en wat zijn de kosten? [Asthma: How much care is used by patients and what are the costs?]. Nationaal Kompas Volksgezondheid, Bilthoven, 2015.
12.
Anzueto A: Impact of exacerbations on COPD. Eur Respir Rev 2010; 19: 113–118.
13.
van Schooten G, van Galen M, Sterkenburg P, et al. Kwaliteit en kosten van de geleverde zorg rond COPD en astma in 2010. Analyse van de waarde van COPD - en astmazorg op basis van declaratiegegevens. [Quality and costs of COPD and asthma healthcare in 2010. Analysis of value of COPD and asthma care based on declaration data.]. Nederland: Zorgverzekeraars. KPMG Plexus, Vektis; 2012.
14.
Transparante ketenzorg Diabetes Mellitus, COPD en VRM. Rapportage zorggroepen over 2013 [Transparant integrated care on Diabetes Mellitus, COPD and Cardiovascular diseases. Report care groups on 2013.]. Ineen, Utrecht; 2014.
15.
WilkinsonTMDonaldsonGCHurstJR. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med2004; 169: 1298–1303.
16.
YawnBP. Early identification of exacerbations in patients with chronic obstructive pulmonary disease. J Prim Care Community Health2013; 4: 75–80.
17.
TrappenburgJCMonninkhofEMBourbeauJ. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax2011; 66: 977–984.
18.
RennardSDecramerMCalverleyPM. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J2002; 20: 793–794.
19.
SlokAHin ‘t VeenJCChavannesNH. Development of the assessment of burden of COPD tool: an integrated tool to measure the burden of COPD. NPJ Prim Care Respir Med2014; 24: 14021.
20.
VanhaechtKvan GervenEDeneckereS. The 7-phase method to design, implement and evaluate care pathways. Int J Pers Cent Med2012; 2: 341–351.
21.
De Graaf R, Tuithof M, van Dorsselaer S, et al. Verzuim door psychische en somatische aandoeningen bij werkenden. Resultaten van de ‘Netherlands Mental Health Survey and Incidince Study-2' (NEMESIS-2). [Absence from work due to psychiatric and somatic disorders in the working population. Results of the ‘Netherlands Mental Health Survey and Incidence Study-2' (NEMESIS-2)]. Utrecht: Trimbos-instituut, 2011.
22.
Hooftman W, van der Klaauw M, Klein Hesselink J, et al. Arbobalans 2011. Kwaliteit van de arbeid, effecten en maatregelen in Nederland [Balans of work 2011. Quality of work, effects and actions in the Netherlands]. the Netherlands: TNO, 2012.
23.
Griens AMGF, Janssen JM, Kroon JDL, et al. Data en feiten 2014, het jaar 2013 in cijfers [Data and facts 2014, the year 2013 in figures]. Den Haag: Stichting Farmaceutische Kengetallen, 2014.
24.
LavoriniFMagnanADubusJC. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med2008; 102: 593–604.
25.
RootmensenGNvan KeimpemaARJansenHM. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method. J Aerosol Med Pulm Drug Deliv2010; 23: 323–328.
26.
Griens AMGF, Janssen JM, Kroon JDL, et al. Data en feiten 2012. Het jaar 2011 in cijfers. [Data and facts 2012. 2011 in figures.]. Den Haag: Stichting Farmaceutische Kengetallen, 2012.
27.
KruisALStallbergBJonesRC. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One2014; 9: e90145.
28.
Inhalatorgebruik [inhalator usage], www.inhalatorgebruik.nl (2015, accessed 3 October 2016).
29.
Goed gebruik inhalatiemedicatie astma en COPD [Correct usage of inhalation medication for Asthma and COPD]. Amersfoort: Long Alliantie Nederland, 2014.
30.
Verdurmen J, Monshouwer K and van Laar M. Factsheet Roken jeugd monitor 2013 [Factsheet smoking youth monitor 2013]. Utrecht: Trimbos Instituut, 2014.
31.
van Gelder BM, Poos MJJC and Harbers MM. Wat zijn de gezondheidsgevolgen van roken? [What are the health consequences of smoking?]. Bilthoven: Nationaal Kompas Volksgezondheid – RIVM, 2014.
32.
van Grootgeest A and van der Woud L. Rapportage, Monitor Rookvrije Scholen 2014 [Report, Monitor Smokefree Schools 2014]. Utrecht: DUO Onderwijs Onderzoek, 2014.
33.
(Research in progress) IJkelenstam N, Verbiest M, Chavannes N, et al. Tobacco use prevention among adolsecents in primary care.
34.
Lijst met doodsoorzaken [List of causes of death]. Den Haag/Heerlen: Centraal Bureau voor de Statistiek (CBS), 2014.
35.
Hooftman W, van der Klaauw M, Klein Hesselink J, et al. Gevaarlijke stoffen [Dangerous substances]. In: van den Bossche S, Geuskens G and Venema A (eds) Arbobalans 2011. Kwaliteit van de arbeid, effecten en maatregelen in Nederland. the Netherlands: TNO, 2012.
36.
UrffMvan den BergJWUilSM. Depression and heart failure associated with clinical COPD questionnaire outcome in primary care COPD patients: a cross-sectional study. NPJ Prim Care Respir Med2014; 24: 14066.
Souza-MachadoCSouza-MachadoAFrancoR. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J2010; 35: 515–521.
39.
SchultzEMMcDonaldKM. What is care coordination?Int J Care Coord2014; 17: 5–24.
40.
HuberMKnottnerusJAGreenL. How should we define health?BMJ2011; 343: d4163.
41.
Talboom-KampEPWAVerdijkNAHarmansLM. An eHealth platform to manage chronic disease in primary care: an innovative approach. Interact J Med Res2016; 5: e5.
